Source: Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Nicola Adderley, Christopher J. Humphreys, Hayley Barnes, Zahra A. Premji, Kerri A. Johannson. Reply: BAL lymphocyte percentage is as good as the company it keeps. Eur Respir J, 57 (2) 2100092; 10.1183/13993003.00092-2021

Member's Comments

No comment yet.

Related content which might interest you: Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no! Source: Eur Respir J, 51 (5) 1800730; 10.1183/13993003.00730-2018 Year: 2018 Pulmonary dendritic cells: playing ball in the BAL? Source: Eur Respir J 2007; 30: 823-824 Year: 2007 Normal values for bronchoalveolar lavage (BAL) differential cell count and lymphocyte subpopulations Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Late Breaking Abstract - Revisiting interpretation of blood eosinophil counts (BECs): data from Brazil Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Alveolar lymphocytes (AL) in healthy individuals are mostly effector T cells. The flow cytometry (FC) lesson for interstitial lung diseases (ILD) evaluation Source: International Congress 2016 – ILD pathogenesis Year: 2016 LSC 2010 Abstract: Increase in serum and sputum perforin expression in persistent asthma: Preliminary results Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Which CD8+ T-cells in asthma? Attacking or defending? Source: Eur Respir J 2016; 48: 287-290 Year: 2016 Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 BAL cell counts in the diagnosis of lung diseases: is there a gain in information? Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002 Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases Source: Eur Respir J 2004; 24: 1000-1006 Year: 2004 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 T lymphocyte subsets in bronchoalveolar lavage: A flow cytometric and its importance in the differntial diagnosis of sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003 The meaning of a high monocyte to lymphocyte ratio in tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses? Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 COPD treatment choices based on blood eosinophils: are we there yet? Source: Breathe, 15 (4) 318; 10.1183/20734735.0254-2019 Year: 2019 Treg cells are expanded among bronchoalveolar lymphocytes in healthy tuberculosis contacts with positive interferon-γ release assay responses Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 Elevated blood eosinophils in bronchiectasis: A distinct phenotype? Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization. Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021